Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.

Naik R, Edmondson RJ, Galaal K, Hatem MH, Godfrey KA.

BJOG. 2008 Dec;115(13):1713-4; author reply 1714. doi: 10.1111/j.1471-0528.2008.01945.x. No abstract available.

2.

Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.

Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM.

Eur J Surg Oncol. 2009 Nov;35(11):1186-91. doi: 10.1016/j.ejso.2009.03.004. Epub 2009 Apr 8.

PMID:
19356887
3.

Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.

Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL 2nd, Maggioni A.

Gynecol Oncol. 2009 Aug;114(2):173-7. doi: 10.1016/j.ygyno.2009.05.004. Epub 2009 May 31.

PMID:
19482344
4.

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.

Sugarbaker PH.

Curr Opin Obstet Gynecol. 2009 Feb;21(1):15-24. doi: 10.1097/GCO.0b013e32831f8f32. Review.

PMID:
19124999
5.

Secondary cytoreductive surgery for isolated nodal recurrence of ovarian cancer.

Bristow RE.

Ann Surg Oncol. 2004 Jul;11(7):639-40. Epub 2004 Jun 14. No abstract available.

PMID:
15197010
6.

Role of cytoreductive surgery in recurrent ovarian cancer.

Harter P, Hilpert F, Mahner S, Kommoss S, Heitz F, du Bois A.

Expert Rev Anticancer Ther. 2009 Jul;9(7):917-22. doi: 10.1586/era.09.49. Review.

PMID:
19589031
7.

A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.

Pomel C, Barton DP, McNeish I, Shepherd J.

BJOG. 2008 Jun;115(7):808-10. doi: 10.1111/j.1471-0528.2008.01692.x. No abstract available.

8.

Re: A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.

Nevin J, Luesley D.

BJOG. 2008 Nov;115(12):1586; author reply 1586-7. doi: 10.1111/j.1471-0528.2008.01868.x. No abstract available.

9.

The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).

Cheng X, Jiang R, Li ZT, Tang J, Cai SM, Zhang ZY, Tian WJ, Zang RY.

Eur J Surg Oncol. 2009 Oct;35(10):1105-8. doi: 10.1016/j.ejso.2009.03.010. Epub 2009 May 13.

PMID:
19443175
10.

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.

Chi DS, Zivanovic O, Palayekar MJ, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Leitao MM, Brown CL, Barakat RR.

Gynecol Oncol. 2009 Jan;112(1):6-10. doi: 10.1016/j.ygyno.2008.10.010.

PMID:
19100916
11.

Surgery in ovarian cancer.

Boardman CH, Webb MJ.

Eur J Gynaecol Oncol. 2001;22(2):89-95. Review.

PMID:
11446487
12.

Surgical management of recurrent ovarian cancer.

Leitao MM Jr, Chi DS.

Semin Oncol. 2009 Apr;36(2):106-11. doi: 10.1053/j.seminoncol.2008.12.002. Review.

PMID:
19332245
13.

Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.

Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C.

Gynecol Oncol. 2009 Aug;114(2):178-82. doi: 10.1016/j.ygyno.2009.04.025. Epub 2009 May 17.

PMID:
19450872
14.

Video-assisted thoracoscopic surgery for recurrent ovarian cancer with a metastatic mediastinal mass.

Ki KD, Lee JM, Tong SY, Lee SK, Kim DH, Kwak YT, Lim SJ.

Onkologie. 2009 May;32(5):274-6. doi: 10.1159/000209320. Epub 2009 Apr 20.

PMID:
19420974
15.

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review.

Gerestein CG, Damhuis RA, Burger CW, Kooi GS.

Gynecol Oncol. 2009 Sep;114(3):523-7. doi: 10.1016/j.ygyno.2009.03.011. Epub 2009 Apr 2. Review.

PMID:
19344936
16.

The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma.

Gerestein CG, Eijkemans MJ, de Jong D, van der Burg ME, Dykgraaf RH, Kooi GS, Baalbergen A, Burger CW, Ansink AC.

BJOG. 2009 Feb;116(3):372-80. doi: 10.1111/j.1471-0528.2008.02033.x.

17.

Primary psammocarcinoma of the ovary or peritoneum.

Poujade O, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P.

Int J Gynecol Cancer. 2009 Jul;19(5):844-6. doi: 10.1111/IGC.0b013e3181a69a26.

PMID:
19574771
18.

A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.

Singh K, Balega J, Chan KK.

BJOG. 2009 May;116(6):865; author reply 865-6. doi: 10.1111/j.1471-0528.2009.02130.x. No abstract available.

19.

Indefinitely prolonged survival after relapse in advanced ovarian cancer: the other end of the telescope.

Kapnick J, Helgason H.

Gynecol Oncol. 2009 Nov;115(2):317-8; author reply 319. doi: 10.1016/j.ygyno.2009.05.024. Epub 2009 Jun 7. No abstract available.

PMID:
19505714
20.

Spread of ovarian cancer after laparoscopic surgery.

Tjalma WA.

Gynecol Oncol. 2000 Jul;78(1):77-8. No abstract available.

PMID:
10873417

Supplemental Content

Support Center